Packaging
10 mL vial
Compounds
Each mL of Rinogonad contains 50 µg of gonadorelin acetate.
Mechanism of the Effect
Rinogonad is transported via the portal venous circulation to the anterior pituitary gland, where it stimulates the release of gonadotropins: follicle-stimulating hormone (FSH) and luteinizing hormone (LH) in females, and promotes spermatogenesis in males.
The onset of action is approximately 2 hours, and the half-life is less than 3 hours. During this period, the peptide is broken down into amino acids and eliminated from tissues.
Use case
Cows:
– Ovarian-origin infertility
– Estrus synchronization programs (in combination with prostaglandin F2α analogs) for precise ovulation timing
– Follicular cysts with or without clinical signs
– Delayed ovulation
– Follicular atresia
– Fertility improvement
– Prevention of infertility through faster onset of first estrus, especially postpartum
Mares:
– Cystic ovarian changes with or without signs of estrus
– Absence of estrus in non-cycling mares
– Ovulation induction
– Ensuring synchronization between ovulation and mating
– Increasing fertility in cases of prolonged or irregular estrus
The amount and how to use
Rinogonad is administered intramuscularly.
Cows: 2 mL deep intramuscular injection
Mares: 10 mL
Caution
–
Drug interference
Do not use Spira Plus® concurrently with macrolide antibiotics.
Maintenance conditions
Store at 2–8°C and protect from light.
